In vivo detection of ifosfamide by 31P*MRS in rat tumours: increased uptake and cytotoxicity induced by carbogen breathing in GH3 prolactinomas
1997

Detection of Ifosfamide in Rat Tumors Using Magnetic Resonance Spectroscopy

Sample size: 12 publication Evidence: moderate

Author Information

Author(s): LM Rodrigues, RJ Maxwell, PMJ McSheehy, CR Pinkerton, SP Robinson, M Stubbs, JR Griffiths

Primary Institution: CRC Biomedical Magnetic Resonance Research Group, St George's Hospital Medical School

Hypothesis

Can carbogen breathing enhance the delivery and efficacy of ifosfamide in rat tumors?

Conclusion

Carbogen breathing significantly increases the uptake of ifosfamide in GH3 prolactinomas, leading to improved tumor growth delay.

Supporting Evidence

  • Carbogen breathing increased ifosfamide uptake by 50%.
  • The average concentration of ifosfamide in GH3 tumors was 0.68 umol g-1 wet weight after carbogen breathing.
  • Significant growth delay was observed in tumors treated with ifosfamide and carbogen breathing.
  • IF alone caused significant growth delay compared to untreated tumors.

Takeaway

Breathing a special gas mix can help a cancer drug work better in tumors in rats.

Methodology

The study used 31P-MRS to monitor ifosfamide pharmacokinetics in rat tumors and assessed the effects of carbogen breathing.

Limitations

The low sensitivity of 31P-MRS compared to chromatographic methods may limit the detection of ifosfamide metabolites.

Participant Demographics

Female Wistar-Furth rats and Ludwig/Wistar/Olac rats were used in the study.

Statistical Information

P-Value

p<0.01

Statistical Significance

p<0.01

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication